Trevi Therapeutics Inc. (TRVI)

TRVI trades at $9.88, 23.5% above the near-term max pain of $8 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($3-$8), reflecting growing call interest at higher strikes. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for TRVI shows an upward trend from 3 to 8, suggesting bullish positioning in longer-dated options. The 86% spread signals divergent expectations across timeframes. Most levels below 9.88 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.